- Focus and Scope
- Is Your Article a Good Fit for JTEHM?
- Publication Frequency
- What is Open Access?
- Review Process
- Types of Papers
- Indexing and Impact Factor
- Editorial Board Policy
- Subscribe via RSS Feeds
- Publication Fees Policy
- Instructions for Authors
- Interactive Content
- Acknowledgements, Conflicts of Interest
Focus and Scope
IEEE Journal of Translational Engineering in Health and Medicine is an open access product that bridges the engineering and clinical worlds, focusing on detailed descriptions of advanced technical solutions to a clinical need along with clinical results and healthcare relevance. The journal provides a platform for state-of-the-art technology directions in the interdisciplinary field of biomedical engineering, embracing engineering, life sciences and medicine. A unique aspect of the journal is its ability to foster a collaboration between physicians and engineers for presenting broad and compelling real world technological and engineering solutions that can be implemented in the interest of improving quality of patient care and treatment outcomes, thereby reducing costs and improving efficiency. The journal provides an active forum for clinical research and relevant state-of the-art technology for members of all the IEEE societies that have an interest in biomedical engineering as well as reaching out directly to physicians and the medical community through the American Medical Association (AMA) and other clinical societies. The scope of the journal includes, but is not limited, to topics on: Medical devices, healthcare delivery systems, global healthcare initiatives, and ICT based services; Technological relevance to healthcare cost reduction; Technology affecting healthcare management, decision-making, and policy; Advanced technical work that is applied to solving specific clinical needs.
JTEHM publishes articles on subjects including, but not limited to, the following representative topics:
- Medical Devices and Systems
- Nano-biosensors and Biosystems
- Medical Imaging and Diagnostic Radiology
- Cardiovascular Devices and Systems
- Neurovascular Devices and Systems
- Rehabilitation Devices and Systems
- Surgical and Interventional Devices
- Bio and Surgical Robotics
- Wearable Sensors and Health Monitoring Systems
- Point-of-Care Technologies
- Wireless and Communication Technologies for Bio-Information Systems
- Electronic Medical Records and Medical Information Systems
- Clinical Ideation
- Clinical Trials
- Clinical Commercialization
- Clinical Engineering
- Global Health
- Harsh Environments
- Hematology and Hemostasis
- Risk and Uncertainty
- Social Determinants of Health
- Law, Ethics, and Policy
We welcome papers with research findings and clinical translation studies from clinicians, engineering faculty and students, industry, policy makers, and the investment community. We also welcome your input and comments on challenges in quality global healthcare, clinical needs, and issues in technology translation to clinical applications on our community forum. We encourage you to make your voice heard in the blogs and commentary sections of this website.
Is Your Article a Good Fit for JTEHM?
We are committed to accepting the highest quality papers possible and to a quick response time for our authors. If you have any question about the suitability of your work for JTEHM, send us an abstract (email@example.com and firstname.lastname@example.org). We will be happy to provide you with a quick response.
JTEHM publishes articles “continuously”; that is, articles are published online as soon as they are available (peer-reviewed and copyedited). On our website, they are subsequently collated into archival “issues” (about 4 issues per year) and “volumes” (one per year).
What is Open Access?
Submitted manuscripts are subject to a rigorous but speedy peer review process. We aim for a standard review time of less than 2 months. The review process is designed to help authors to improve their manuscripts by giving them constructive comments on how to improve their paper, and to publish only those articles which comply with general quality criteria of a scholarly paper, especially originality, clarity, references to related work and validity of results and conclusions. In addition, we require a translational element to the work or a clear path to clinical application.
When we receive a manuscript, the Managing Editor will first decide whether the manuscript meets the formal criteria specified in the JTEHM template and, in consultation with the Editor in Chief, whether it fits within the scope of the journal. When in doubt, the editor will consult other members of the Editorial Board. Manuscripts are then assigned to an Associate Editor, who sends each paper to 2 external experts for peer review. Authors are required to suggest at least 1 peer-reviewer (who does not have a conflict of interest) during the submission process.
Speed of Peer-Review
Bioengineering is a fast-moving field and we acknowledge the need of our authors to communicate their findings rapidly. We therefore aim to be extremely fast (but still thorough and rigorous) in our peer-review process. However, actual times needed to review and edit papers vary, and primarily depend on the quality of the paper upon first submission. Normally we cannot give any guarantees on the speed of peer-review or publication, but we aim for an average decision time of 2 months after submission for papers sent out for peer-review. There will, however, always be outliers.
Manuscripts should meet the following requirements: the study conducted is ethical; the material is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data; the information is important; there is a clear translational focus or path to clinical application; and the topic is interesting for our readership. See instructions for authors here.
Informed consent, protection of privacy and other human rights are further criteria against which manuscripts involving human subjects will be judged. Papers describing investigations on human or animal subjects must include a statement that the study was approved by the institutional review board.
Our ethical requirements for submitted manuscripts are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, drawn up by the International Committee of Medical Journal Editors (JAMA 1997;277:927-934). JTEHM also supports and acts in line with the Editorial Policy Statements of the Council of Science Editors (http://www.cbe.org/services/draft_approved.cfm).
Types of Papers
To read more about the types of manuscripts accepted by JTEHM see our Instructions for Authors page here.
Indexing and Impact Factor
JTEHM is indexed in PubMedCentral, Medline, DOAJ, SCOPUS, EMBASE, and other major bibliographic indexes and abstracting services. All papers are published in Xplore, and while, as a new journal, we do not yet have an impact factor, we are actively pursuing other indexes and should receive an impact factor soon.
Editorial Board Policy
Purpose: The Editorial Board is a group of outstanding individuals committed to helping JTEHM produce an excellent multidisciplinary scientific publication of the highest quality. Editorial Board members are appointed by the editor-in-chief for a 3-year term that is renewable. Nominations for Editorial Board appointments come from a variety of sources including self-nominations, the current Editorial Board, journal authors, and readers. The Editorial Board aims to constitute an appropriate interdisciplinary mix from a wide range of disciplines, including health care researchers, researchers from the engineering sciences, social sciences, industry, practicing clinicians, and student representatives on our Junior Associate Editorial Board. Our board members are productive and highly respected members of the scientific and industry communities.
Subscribe to RSS Feeds
Use your favorite newsreader or live bookmarks to stay abreast of the latest research published in JTEHM. Copy this link, also found in the Latest News icon above, and paste it into your newsreader’s Add Feed function. Refer to your newsreader’s instructions for further help.
Publication Fees Policy
As we aim to publish widely indexed, carefully copyedited, high-quality manuscripts that are also deposited in repositories such as PubMed Central, publication of an accepted paper requires expensive production steps such as copyediting, reference checking and XML tagging. In the editing and production stage, IEEE employs professional full-time staff and freelancers, and we have to pay for these services. To defray these costs (and because we do not sell subscriptions like toll-access journals) we require authors to pay certain fees.
Authors publishing in JTEHM pay an article processing fee open access fee (also called an open access, or OA fee) only in case of acceptance. The fees are $1350 for up to 8 pages, $250 each for pages 9 and 10, and $350 for each additional page. There is a 15% discount for EMB Society members.
These fees are usually funded from research grants, and new researchers in the area are urged to budget for open access publications in their grant proposals, much as they budget for conference presentations.
When comparing the cost of publishing in JTEHM against the cost of publishing in other OA journals, please consider that 1) IEEE journals’ reputation for quality, and 2) JTEHM employs professional copyediting after acceptance, which is a service many OA journals with lower costs do not provide. Given these considerations, JTEHM is currently one of the most cost-effective OA journals on the market.
Article processing fees for Open Access journals have become an increasingly accepted method to defray the costs for publication, and fortunately most institutions have developed mechanisms and funding sources to cover publication costs in high-quality open access journals.
Instructions for Authors
Submit articles for publication in JTEHM through Manuscript Central. All submissions must follow the IEEE JTEHM templates. Upon acceptance, authors are encouraged to include either a video abstract or a high-resolution image for both Xplore and JTEHM.
Beginning January 1, 2018, biosketches and author pictures will no longer be published as part of EMBS Journal articles.
JTEHM has a hard cap of 10 pages for manuscript length. Manuscripts that exceed 10 pages in the template will not be admitted for review.
JTEHM welcomes comments and guest blogs from the translational engineering community. Comments are moderated, so there will be a short lag before comments are posted. All papers are encouraged to include video, tutorials, interactive content, and high-resolution images as well.
Acknowledgements, Conflicts of Interest
A description of sources of funding, financial disclosure, and the role of sponsors must be included in the Acknowledgements section of the manuscript.
Authors must also disclose any personal financial interests related to the subject of the manuscript. It is not unusual for JTEHM authors to be owners or employees of companies that are developing the technologies described in their manuscript. There is nothing wrong with this, but editors, reviewers, and readers should be made aware of such conflicts of interests; thus, these facts must be disclosed.